Organon Acquired by Sun Pharma | Healthcare M&A Deal

Sun Pharma has agreed to acquire Organon, a pharmacy business in New Jersey. The Organon acquisition supports Sun Pharma’s healthcare M&A strategy by expanding its pharmaceutical portfolio and strengthening capabilities across pharmacy-related products. Sun Pharma acquisitions in NJ align with demand for branded and specialty medicines, supporting broader access for patients and customers. The merger acquisition is a strategic acquisition by a corporate buyer, with deal size undisclosed, and is currently announced pending definitive closing terms.